Act Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Act Capital Management LLC
CRD #307272
SEC #801-122045
CIK #0001442273
AUM 163.9 M (2026-06-03)
Employees 2 (100% Investors, 0% Brokers)
Fees
Minimum
Phone610-688-2833
Address100 West Lancaster Avenue
Wayne, PA 19087
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
2502001501005002010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
Item 5: Fees and Compensation
The Firm is paid by the Fund, as of the beginning of each calendar month, a
management fee at the rate of two percent (2.0%) per annum. Please refer to the Fund’s
offering documents for a full explanation of Fund fees and expenses.

   A. Management fees are not generally negotiable by investors in the Fund. ACT may
      also elect to waive or reduce any management fees payable by an investor in the
      Fund (in limited instances). Except as set forth below, management fees are
      typically non-refundable once paid.

   B. In addition to paying investment management fees and performance-based
      compensation, the Fund may also be subject to other investment expenses such as
      brokerage fees, commissions and interest expenses. Additional fees may include

      legal, accounting and consulting expenses, auditing and tax preparation expenses,
      news, quotation and computer equipment and services, dues and subscriptions,
      expenses incurred for research and investment information related purposes, for
      Fund investors expenses relating to the offer and sale of limited Fund interests and
      other expenses related to the Fund. Please also review the offering and related
      documents of the Fund for a description of the fees and expenses associated with
      an investment therein. See also Item 12 for a discussion of brokerage fees paid by
      the Fund.

   C. Neither ACT nor any of its supervised persons accepts compensation for the sale
      of securities or other investment products, including asset-based sales charges or
      service fees from the sale of mutual funds.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
Item 7: Types of Clients
As described in Item 4, the Firm’s Clients currently consist of private Funds. For the
Fund, Investors must contribute a minimum of $250,000 (which may be waived or
reduced at the General Partner’s discretion) on a case by case basis.
Sector Form 13F Holdings Value ($M)
Krystal Biotech Inc 15.6
Chevron Corp 15.5
Celcuity Inc 10.5
Manhattan Pharmaceuticals Inc 8.3
Abivax Sa 7.9
Amazon Com Inc 6.9
Viking Therapeutics Inc 6.8
Arrowhead Research Corp 5.2
Nektar Therapeutics 5.1
Cytokinetics Inc 4.3
View All
Holdings by Sector ($M)
200160120804002021202320252027
Type Form D Funds Date Sold AUM
HF Act Capital Partners LP [2020-02-28] 22.9 M 33.5 M
Filed 2025-08-15 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Gingko Fund LLC 2020-02-28 78.8 M
HF The 21st Century Ecker Family Partnership 2020-02-28 2.8 M
HF The Ecker Family Partnership 2020-02-28 4.0 M
HF Whitethorne Fund LLC 2020-02-28 29.3 M
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.2
(b) Individuals (high net worth individuals) 11 15.3
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 5 148.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 21 163.9
By Discretionary
Discretionary 21 163.9
Non-Discretionary 0 0.0
Total 21 163.9
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 163.9
Total 21 163.9
Form D Directors Role # Filings # Firms 2011 - 2026
Amir Ecker Executive Officer 4 2
Act Capital LLC Director 3 2
EDGAR Form CIK 2011 - 2026
13F-HR [0001442273]
SC 13G [0001442273]
Form 13D/13G Filer Form 13D/13G Subject Filed
Act Capital Management LLLP HyreCar Inc [2019-01-04]
Act Capital Management LLLP Hancock Jaffe Laboratories Inc [2018-06-15]
Act Capital Management LLLP Xspand Products Lab Inc [2018-05-09]
Act Capital Management LLLP Soligenix Inc [2017-11-07]
Act Capital Management LLLP Ampio Pharmaceuticals Inc [2017-10-27]
Act Capital Management LLLP Akers Biosciences Inc [2014-02-25]
Act Capital Management LLLP Alldigital Holdings Inc [2014-02-13]
Act Capital Management LLLP Mobivity Holdings Corp [2013-08-01]
Act Capital Management LLLP Atheronova Inc [2013-02-01]
Act Capital Management LLLP Ampio Pharmaceuticals Inc [2013-01-29]
View All
Firm Profile (Form ADV)
ServesInstitutional, Retail
Fund TypesHedge Fund
Comparable Firms State AUM
Chesapeake Capital Corporation
FL 171.9 M
Paw Capital Partners LP
CT 166.8 M
TR Capital Management LLC
NY 166.3 M
Womack Financial LLC
TX 164.7 M
Glaxis Capital Management LLC
FL 160.8 M
Little River Capital Partners LP
160.1 M
SCG Asset Management LLC
IL 158.7 M
Nitor Capital Management LLC
NJ 158.6 M
Settian Capital LP
FL 156.5 M
Brandywine Asset Management Inc
PA 156.0 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com